• News
  • SAN DIEGO
  • BioTech

ViaCyte files investigational NDA, device master file with FDA

ViaCyte Inc. has filed an investigational new drug application with the FDA seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!